Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases. Issue 8 (17th July 2020) - Kim, Erin M; Randall, Cara; Betancourt, Renee; Keene, Staci; Lilly, Amy; Fowler, Mark; Dellon, Evan S; Herfarth, Hans H